Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Centene NYSECNC A Decade of Strong Financial Performance and Growth

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Healthcare-and-Tech
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

If an individual had invested $1000 in Centene (NYSE:CNC) stock a decade ago, it would now be valued at $5,124.36 as of February 26, 2024, with CNC priced at $80.35. Centene has surpassed the market by 7.05% annually over the past 10 years, delivering an average yearly return of 17.54%. The stock has displayed notable growth, boasting a 34% increase in the last five years.

Centene’s revenue has seen a steady compound growth rate of 23% in the past five years, showcasing strong performance in this area. Despite a recent dip in stock price, the company’s revenue growth and earnings trends remain key indicators of its business success.

Overall, Centene has exhibited robust financial performance in the last decade, solidifying its position as a healthcare industry leader focused on innovation and expansion. The company’s strategic efforts include strengthening its foundation through infrastructure enhancements and elevating its growth trajectory for long-term prosperity.

CNC Stock Shows Strong Price Momentum on February 26, 2024

On February 26, 2024, CNC stock showed positive price momentum as it traded near the top of its 52-week range and above its 200-day simple moving average. The stock opened at $80.64, which was $0.42 higher than its previous close, indicating a strong start to the trading day. Throughout the day, CNC shares continued to climb, with a price increase of $0.61 since the market last closed. This represented a 0.76% rise in the stock price, showing a bullish trend for CNC on that particular day. Investors and analysts often look at price momentum as an indicator of a stock’s potential for future growth. When a stock is trading near the top of its 52-week range and above its 200-day moving average, it can signal that the stock is in an uptrend and may continue to see price appreciation in the future. Overall, CNC’s performance on February 26, 2024, was positive, with the stock showing strong price momentum and posting gains throughout the trading day. Investors will be keeping a close eye on CNC in the coming days to see if this positive momentum continues and if the stock can sustain its upward trajectory.

CNC Stock Performance Shows Strong Growth in Total Revenue and Net Income for 2023

On February 26, 2024, CNC stock performance showed steady growth in total revenue and net income compared to the previous year. According to data from CNN Money, CNC reported a total revenue of $154.00 billion for the past year, which is a 6.54% increase from the previous year.

Net income for CNC was reported at $2.70 billion for the past year, showing a significant increase of 124.79% from the previous year.

Earnings per share (EPS) for CNC also showed strong growth, with an EPS of $4.95 for the past year, representing a 139.75% increase from the previous year.

Overall, CNC stock performance on February 26, 2024, reflected positive growth in total revenue, net income, and earnings per share compared to the previous year. Investors may view these results as a sign of the company’s strong financial performance and potential for future growth. It will be interesting to see how CNC continues to perform in the coming quarters and whether it can maintain its positive momentum in the market.

Tags: CNC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Assets (3)

Financial Analyst Upgrades Price Target for Newmark Group to 1125

Biopharmaceutical Stock Market Today (1)

GSKs Gepotidacin A Potential Game Changer in the Fight Against Gonorrhea

Global supply chain

Wedbush Analyst Reiterates Outperform Rating for Rithm Capital with 13 Price Target

Recommended

FCBC stock news

Impax Asset Management Group plc Reduces Stake in Snap Inc. as Insiders Sell Off Shares

2 years ago
The Trade Desk Stock

The Trade Desk: A Market Conundrum of Conflicting Signals

3 months ago
Intel Stock

US Government Holds Massive Intel Share Position, Creating Market Uncertainty

5 months ago
Nuvalent Stock

Nuvalent Shares Surge on Promising Clinical Trial Results

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Trending

KemPharm Stock
Analysis

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

by Kennethcix
February 8, 2026
0

Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations...

Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
SuRo Capital Stock

SuRo Capital Sharpens Focus on AI Infrastructure Investments

February 8, 2026
Chicago Atlantic Real Estate Finance Stock

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

February 8, 2026
RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion
  • Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit
  • SuRo Capital Sharpens Focus on AI Infrastructure Investments

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com